Examining the long-term effects of COVID-19 on cancer screening disparities
Assessing the long-term impacts of the COVID-19 pandemic on disparities in cancer screening and follow-up (RESTORE)
This study is looking at how the COVID-19 pandemic has changed cancer screening and follow-up services for people, especially those from underserved communities, like Latinx patients, to find ways to make it easier for them to get the care they need.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arizona NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project ID | NIH-11190143 on NIH RePORTER |
What this research studies
This research investigates how the COVID-19 pandemic has affected cancer screening and follow-up services, particularly among underserved populations. It aims to gather data on the disparities in cancer care access and identify strategies to improve screening rates in communities that have been disproportionately impacted. The study will focus on patients served by federally qualified health centers, especially those from Latinx backgrounds, to understand their unique challenges and needs in accessing cancer care post-pandemic.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults, particularly those from Latinx communities and those served by federally qualified health centers who have experienced barriers to cancer screening due to the pandemic.
Not a fit: Patients who have not been affected by the pandemic in terms of access to cancer screening or who do not belong to underserved populations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer screening and follow-up services for underserved populations, ultimately reducing cancer disparities.
How similar studies have performed: Other research has indicated that addressing healthcare disparities can lead to significant improvements in cancer screening rates, suggesting that this approach may be effective.
Where this research is happening
Tucson, United States
- University of Arizona — Tucson, United States (Active)
Researchers
- Principal investigator: Coronado, Gloria D — University of Arizona
- Study coordinator: Coronado, Gloria D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.